Literature DB >> 938029

In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin.

T C Eickhoff, J M Ehret.   

Abstract

The in vitro effect of cefoxitin, cefamandole, cephalexin, and cephalothin was tested against 645 strains of bacteria recently isolated from clinical sources. Against gram-positive organisms cephalothin and cefamandole were the most effective, generally being three- to fourfold more active than cephalexin or cefoxitin. Enterococci were not inhibited by less than 25 mug of any of the antibiotics per ml. Against Enterobacteriaceae, cefoxitin and cefamandole were the most active. An exception was the Enterobacter strains, against which cefoxitin was the least effective. None of the Pseudomonas aeruginosa strains were susceptible to 100 mug of any of the cephalosporins per ml. Cefamandole was the most active agent against Neisseria meningitidis and Neisseria gonorrhoeae. It was also the most effective agent against Haemophilus influenzae, even when taking into account a threefold inoculum effect.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 938029      PMCID: PMC429663          DOI: 10.1128/AAC.9.6.994

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Effect of inoculum and of beta-lactamase on the anti-staphylococcal activity of thirteen penicillins and cephalosporins.

Authors:  L D Sabath; C Garner; C Wilcox; M Finland
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

2.  An in vivo comparison of cefoxitin, a semi-synthetic cephamycin, with cephalothin.

Authors:  J M Hamilton-Miller; D W Kerry; W Brumfitt
Journal:  J Antibiot (Tokyo)       Date:  1974-01       Impact factor: 2.649

3.  Susceptibility of clinical isolates of bacteria to cefoxitin and cephalothin.

Authors:  R C Moellering; M Dray; L J Kunz
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

4.  Cefoxitin and cephalothin: antimicrobial activity, human pharmacokinetics, and toxicology.

Authors:  W Brumfitt; J Kosmidis; J M Hamilton-Miller; J N Gilchrist
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

5.  Rapid detection of ampicillin-resistant Haemophilus influenzae and their susceptibility to sixteen antibiotics.

Authors:  R B Kammer; D A Preston; J R Turner; L C Hawley
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191

6.  Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

7.  Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

8.  Cefoxitin, a semisynthetic cephamycin antibiotic: resistance to beta-lactamase inactivation.

Authors:  H R Onishi; D R Daoust; S B Zimmerman; D Hendlin; E O Stapley
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

9.  Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.

Authors:  S Eykyn; C Jenkins; A King; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1973-06       Impact factor: 5.191

  9 in total
  21 in total

1.  In vitro activity of HR 756, a new cephalosporin, against Neisseria gonorrhoeae.

Authors:  P R Murray; J L Christman; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

2.  Inoculum effect of β-lactam antibiotics.

Authors:  Justin R Lenhard; Zackery P Bulman
Journal:  J Antimicrob Chemother       Date:  2019-10-01       Impact factor: 5.790

3.  In vitro susceptibility of Haemophilus influenzae to sulfamethoxazole-trimethoprim and cefaclor, cephalexin, and cephradine.

Authors:  R Sinai; S Hammerberg; M I Marks; C H Pai
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

4.  Growth curves, microscopic morphology, and subcultures of beta-lactamase-positive and -negative Haemophilus influenzae under the influence of ampicillin and cefamandole.

Authors:  E Yourassowsky; M P Van Der Linden; M J Lismont
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

5.  Lack of correlation between beta-lactamase production and susceptibility to cefamandole or cefoxitin among spontaneous mutants of Enterobacteriaceae.

Authors:  J L Ott; J R Turner; D F Mahoney
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

6.  Bactericidal activity of cefoperazone with CP-45,899 against large inocula of beta-lactamase-producing Haemophilus influenzae.

Authors:  P K Yu; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

7.  Clinical and bacteriological evaluation of cefoxitin therapy in children.

Authors:  J A Jacobson; J I Santos; W M Palmer
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

8.  Effect of inoculum size on the susceptibility of Haemophilus influenzae b to beta-lactam antibiotics.

Authors:  V P Syriopoulou; D W Scheifele; C M Sack; A L Smith
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

9.  Prospective comparison of cefoxitin and cefazolin in infections caused by aerobic bacteria.

Authors:  M Gurwith; W Albritton; B Lank; G Harding; A Ronald
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

10.  Beta lactamase resistance of newer cephalosporins and antimicrobial effectiveness against gram-negative bacilli.

Authors:  W E Farrar; N M O'Dell
Journal:  Infection       Date:  1977       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.